Antinflamatorios no esteroideos y seguridad cardiovascular: ¿es naproxeno más seguro que celecoxib? Nuevas evidencias

• Autores: Antonio Alcántara Montero, A. González Curado
• Localización: Revista de la Sociedad Española del Dolor (SED), ISSN 1134-8046, Vol. 25, Nº. 6, 2018, págs. 366-368
• Idioma: español
• DOI: 10.20986/resed.2016.3549/2016
• Títulos paralelos:
  • Non-steroidal anti-inflammatory drugs and cardiovascular safety: is naproxen safer than celecoxib? New evidences
• Enlaces
  • Texto completo (pdf)
• Referencias bibliográficas
  • (2004). Food and Drug Administration. FDA public health advisory: safety of Vioxx.
  • (2013). Coxib and traditional NSAID Trialists' Collaboration Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory...
  • (2014). Nonsteroidal anti-inflammatory drugs and cardiovascular thrombotic risk. Joint Meeting of the Arthritis Advisory Committee and the...
  • MacDonald, TM,Hawkey, CJ,Ford, I,McMurray, JJ,Scheiman, JM,Hallas, J. (2017). Randomized trial of switching from prescribed non-selective...
  • Nissen, SE,Yeomans, ND,Solomon, DH,Lüscher, TF,Libby, P,Husni, ME. (2016). Cardiovascular safety of celecoxib, naproxen, or ibuprofen for...